Neurescue news
COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a clinical-stage medical device company bringing to market the world’s first computer-aided balloon catheter for aortic occlusion, today announced that medical device industry veteran Mette-Marie Harild has been appointed to the Neurescue board of directors. Most recently the regional vice president of Medtronic’s largest sub-region in Europe, Middle East and Afri
- Cardiac arrest is one of the leading causes of death in the U.S. and globally.
- It has a survival rate of 1 in 10 people with current treatment.
- The Neurescue device is designed to increase blood flow to the brain and heart during life-threatening emergencies such as cardiac arrest.
In April 2013, final-year Danish medical student Habib Frost was called out to an emergency: a four-month old girl had just suffered cardiac arrest. Frost’s team tried defibrillation, but to no avail. Immediately after, the team was called out again: another case of cardiac arrest, this time a woman in her 30s. Once again, Frost was powerless to save her life.
“I felt devastated,” he says. “I knew I was not meant to let myself be affected to such a degree, but
COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced